Keyphrases
Nanoparticles
100%
Cholangiocarcinoma
100%
Cancer Cell Invasiveness
100%
MiR-210
100%
CXCR4 Antagonist
85%
Cholangiocarcinoma Cells
57%
Anti-miR
28%
Drug Resistance
28%
Metastasis
28%
Anticancer Activity
28%
Biological Factors
14%
Inhibitory Effect
14%
Therapeutic Efficacy
14%
Effective Treatment
14%
MicroRNA
14%
In Vitro Activity
14%
Cell Migration
14%
Gemcitabine
14%
Treatment Options
14%
C-X-C Chemokine Receptor Type 4 (CXCR4)
14%
Hypoxia
14%
Therapeutic Outcome
14%
Antitumor Activity
14%
Cytotoxic Activity
14%
Cisplatin
14%
Hypoxia-inducible
14%
Cell Killing
14%
Tumor-bearing Mice
14%
Chemokine Receptor CXCR4
14%
Invasiveness
14%
Xenograft Model
14%
In Vivo Biodistribution
14%
Liver Malignancy
14%
Combination Treatment
14%
Delivery Platform
14%
Intravenous Treatment
14%
MiRNA Delivery
14%
Activity Study
14%
Drug Resistance Reversal
14%
Nanotherapeutics
14%
RNA Therapeutics
14%
Cancer Stem-like
14%
Anti-miRNA
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Malignant Neoplasm
100%
Bile Duct Carcinoma
100%
microRNA 210
100%
Chemokine Receptor CXCR4 Antagonist
54%
microRNA
36%
Drug Resistance
27%
Hypoxia
18%
Biodistribution
9%
Neoplasm
9%
Mouse
9%
Gemcitabine
9%
Combination Therapy
9%
Cisplatin
9%
Antitumor Activity
9%
Chemokine Receptor CXCR4
9%
Cytotoxicity
9%
Biological Factor
9%